From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Notes from Underground – Most read articles for the week ending 21 Sept

By Darren Atwater | Sunday 22 September 2024


 


Here are the most read articles and the most listened-to Bearcasts over the past seven days. The most read non-Tom article last week is Made Tech – new contract, what about profit as well as “revenue expectations”? by Steve Moore at number 1 or number 10 including Bearcasts. 

The most-read ShareProphets articles this week were:

  1. Made Tech – new contract, what about profit as well as “revenue expectations”?
    Describing itself as “a leading provider of digital, data, and technology services to the UK public sector”, Made Tech Group (MTEC) has issued a “New contract with the Department for Education” announcement and what of the shares currently more than 7% higher in response at 17p?

  2. A $686 million short created by a Wanke to go to zero from Evil Banksta: doom for Technology Minerals
    Evil Banksta has been in touch and Liverpool’s greatest numbers man since Ken Dodd has a new stock where he is short and you can short too. He opines:

  3. The View From The Montana Log-Cabin As Gold Breaks Even Higher
    Gold closed the week at the dizzy heights of $2,578 – another all-time weekly high – having posted a bit over $2,580 during Friday. It was a good bit higher than last week’s close at $2,497….so much for the correction then! Moreover, Gold stocks has a ripping week as can be seen on my chart of Gold vs the Golding-mining ETFs GDX (majors), GDXJ (juniors) and GOEX (explorers).

  4. DP Poland: a recovery buy at 10.75p?
    Historically DP Poland (DPP) has struggled with continual losses and its share price history reflects that and numerous fund raises. This website has been consistently bearish. However, there are interims and a trading statement out today…

  5. Fintel – interims, is it really “Strong performance; strategic expansion to accelerate future growth”?
    ‘Fintech and support services’ provider to the UK retail financial services sector, Fintel (FNTL) has announced results for the first half of 2024 headlined “Strong performance; strategic expansion to accelerate future growth”. So what of a current approaching 4% lower share price response towards 300p?

  6. Xaar – interims, “success in new market sectors”?
    Inkjet printing technology company Xaar (XAR) has announced results for the first half of 2024 headlined “Resilient performance against a difficult market backdrop” and including “net cash of £6.8 million, up 10%, driven by disciplined cash management… Market uncertainty persists although expectations for the full year remain unchanged… We are pleased with customer engagement and expect more OEM product launches during the second half of the year”. So what of a share price down to below 100p in response?

  7. Has Skinbiotherapeutics misled us all, underpromising on Croda?
    My reading and that of an unimpressed Mr. Market of yesterday’s RNS was that Skinbiotherapeutics (SBTX) will get Croda revenues for sure but probably not until H2 next year following an April 8 launch. But maybe we were misled or at least steered down the wrong path in yesterday’s RNS?

  8. Centamin – What To Do With Takeover? Ouzo First, Then….
    I’ve been tipping fully-listed Egyptian Gold-miner Centamin (CEY) for an age. This week saw a seemingly done deal for a takeover by AngloGold at a decent-ish premium to the previously prevailing share price. Some might be disappointed at the result (including me) but the harsh reality seems to be it is almost a done deal (although there is the outside chance of a competing offer), so what to do now.

  9. BREAKING: Deutsche says Avacta a sell as AVA6000 data “could not meet expectations”
    Analyst Paul Cudden does not mince his words. Social media defenders of Avacta (AVCT), always a thick bunch of conspiracy theorists, claim he is only bearish as Avacta used to employ his Mrs but fired her. Whether that is the case or not, Deustche would not allow research to go out based purely on a grudge and the loons cannot argue with the FACTS. Well they can but that is why they are loons.

  10. Helium, a bubble & the stockmarket minnows that will collapse
    Tom Winnifrith challenged me to talk about Helium at ShareStock 2024. Never one to back down from a challenge, I tried to do my best to cover the subject. I knew was an inert gas and the current market hype told me it was a bubble. But why? Beyond that I knew very little (pass me the postage stamp?).

The most listened-to Bearcasts this week were:

  1. Tom Winnifrith Bonus Bearcast: Skinbiotherapeutics and the Croda news, why I am still not buying There is news today which has the Skins (SBTX) obsessives in a lather though Mr. Market is not wowed. I explain my two big concerns 

  2. Tom Winnifrith Bearcast: Why I'm relaxed about Optibiotix despite the share price & have I said how much I despise Martin Sorrell? I start with a service announcement about tomorrow. Then I look at S4 Capital (SFOR), US and UK base rates, Optibiotix (OPTI), Parkmead (PMG), Powerhouse (PHE) and StreaksAI (STK)

  3. Tom Winnifrith Bearcast: Skinbiotherapeutics needs to make a statement In today's podcast I discuss Skins (SBTX) as its shares tank, Avacta (AVCT), Manolete (MANO), Zephyr Energy (ZPHR) and Milton Capital (MII)

  4. Tom Winnifrith bonus bearcast: Kefi kicks me in the gonads again with its use of language I discuss today's RNS from Kefi Gold & Copper (KEFI) and how 'arry's language kicks me in the bollocks again. The shares are, however, very cheap.

  5. Tom Winnifrith Bearcast: Is there any rogue in town who has not danced at the Oracle? I discuss the fattening of the West and what that means, touching on my personal podcast up earlier HERE.I talk about Kefi (KEFI), Oracle (ORCP) and Zephyr (ZPHR).

  6. Tom Winnifrith Bearcast: Thanks to the NHS there will be a Sharestock next year I explain why. Please do book early. Then I look at Blackbird (BIRD), Red Rock (RRR), Wishbone (WSBN) and other dogs of that ilk.

  7. Tom Winnifrith Bearcast: the moment of truth arrives I refer to my new underpants. I then discuss the US election and why, in an economic sense, it does not really matter. Finally the silence at the Supply@ME Capital (SYME) fraud stable and what it means. 

  8. Tom Winnifrith Bearcast: 100 days to Christmas I explain why I know that fact before discussing Chariot Limited (CHAR),Predator Oil & Gas (PRD), Critical Metals (US:CRML) and Technology Minerals (TM1)

  9. Tom Winnifrith Bearcast: wise words from Jim Mellon, Tom Cross should have headed I start with Parkmead (PMG) after today's expose, then calls to lighten rules on fund managers post Woodford, Swanny, Chill Brands (CHLL),Probiotix (PBX) and failing NEDs and then AIM and IHT removal.
This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Thursday »

LUCE

Luceco – a trading recovery Buy?...

 

Quiz

The ShareProphets Sunday Pub Quiz #260

Thursday »

TM1

Rat. Sinking Ship. Technology Minerals

Wednesday »

Bearcast

Tom Winnifrith Bearcast: Another red flag at Cirata

 

Quiz

The ShareProphets Sunday Pub Quiz #259

 

DPP

DP Poland: a recovery buy at 10.75p?

 

Quiz

The ShareProphets Sunday Pub Quiz #258

 

Tom

Photo Article from Sharestock: tea

Time left: 08:15:21